Sintx Technologies (NASDAQ:SINT) Director Acquires $21,848.60 in Stock

Sintx Technologies, Inc. (NASDAQ:SINT) Director Christopher Michael Lyons bought 7,534 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was purchased at an average price of $2.90 per share, with a total value of $21,848.60. Following the transaction, the director directly owned 8,292 shares in the company, valued at $24,046.80. The trade was a 993.93% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Christopher Michael Lyons also recently made the following trade(s):

• On Wednesday, February 25th, Christopher Michael Lyons bought 758 shares of Sintx Technologies stock. The stock was purchased at an average cost of $2.96 per share, with a total value of $2,243.68.

Sintx Technologies Trading Up 0.8%

Shares of SINT stock traded up $0.02 during trading hours on Tuesday, hitting $2.77. 20,589 shares of the company’s stock were exchanged, compared to its average volume of 34,135. The company has a market capitalization of $10.20 million, a PE ratio of -0.49 and a beta of 0.66. Sintx Technologies, Inc. has a 12-month low of $1.71 and a 12-month high of $6.78. The business’s 50 day simple moving average is $3.28 and its 200-day simple moving average is $3.67.

Analyst Upgrades and Downgrades

Several analysts have weighed in on SINT shares. Ascendiant Capital Markets lowered their price target on shares of Sintx Technologies from $25.00 to $16.00 and set a “buy” rating for the company in a research note on Monday, December 8th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Sintx Technologies in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Sintx Technologies currently has an average rating of “Hold” and an average price target of $16.00.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC lifted its holdings in Sintx Technologies by 33.5% in the 2nd quarter. Geode Capital Management LLC now owns 15,339 shares of the company’s stock worth $49,000 after buying an additional 3,848 shares during the period. Veracity Capital LLC increased its stake in shares of Sintx Technologies by 10.3% during the third quarter. Veracity Capital LLC now owns 79,928 shares of the company’s stock valued at $327,000 after buying an additional 7,464 shares during the period. Finally, Virtus Wealth Solutions LLC bought a new position in shares of Sintx Technologies during the third quarter valued at approximately $388,000. Hedge funds and other institutional investors own 18.38% of the company’s stock.

About Sintx Technologies

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.